Purkiss Capital Advisors LLC
Position in TMO — Thermo Fisher Scientific Inc.
CIK 2053150
RIDGEFIELD, CT
Position in TMO
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$2,487,246
+$216,378 QoQ
Shares Held
4,961
+7.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.18%
of 13F equity value
Holder Rank
#1,090
of 2,606 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 7%
Shared 0%
None 93%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Purkiss Capital Advisors LLC holds $2,716,202 across 2 Diagnostics & Research names. TMO ranks #1 (91.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
This page
|
4,961 | $2,487,246 | |
| 2 | DHR |
Danaher Corp /De/
|
1,202 | $228,956 |
All Filings in TMO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,487,246 | 4,961 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $2,270,868 | 4,620 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $2,407,035 | 4,154 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $2,171,919 | 4,478 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $1,400,864 | 3,455 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $1,129,054 | 2,269 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $1,121,095 | 2,155 | Shares | Sole | 2025-02-05 | |
| No filing history on record for this holder in this stock. | ||||||